Proud to Be Part of ARM: Advancing the Future of Regenerative Medicine Together
At Excellos, we are honored to be a member of the Alliance for Regenerative Medicine—a driving force behind the progress, innovation, and advocacy that is transforming the field of regenerative medicine.
Alliance for Regenerative Medicine also known as ARM
ARM is the global voice of the cell and gene therapy sector, representing over 400 members across 25 countries—including biotechnology companies, academic and medical institutions, and patient advocacy groups. Their mission? To accelerate the development and accessibility of advanced therapies that are not just life-changing—but potentially curative.
ARM is leading the charge on multiple fronts:
- Driving Scientific Innovation By convening the brightest minds in cell and gene therapy, ARM fosters collaboration across the sector—helping to break down barriers in process development, manufacturing, and scale-up. This kind of cross-sector cooperation is essential to delivering cutting-edge therapies to patients faster.
- Championing Bold Advocacy ARM’s voice is powerful and effective. They work directly with global regulators—like the FDA and EMA—to advance policies that modernize healthcare systems and regulatory frameworks. Their advocacy has already resulted in major wins, including the creation of the RMAT designation and influencing new FDA guidance to bring more flexibility to the field.
- Providing Sector-Leading Insights ARM offers unparalleled access to industry data, from clinical trial trends and corporate partnerships to policy changes and investment outlooks. This insight is critical as we navigate the dynamic landscape of cell and gene therapy development.
- Creating a Thriving Ecosystem ARM brings the community together—through exclusive workshops, forums, and global conferences that draw thousands of industry leaders. Their events aren’t just informative—they’re energizing, collaborative, and deeply impactful.
At Excellos, we share ARM’s commitment to building a healthier future through innovation in regenerative medicine. As a member, we are proud to stand alongside a coalition that is actively shaping policy, championing patient access, and pushing the boundaries of what’s possible in healthcare.
What ARM Membership Brings to Our Partners
Our participation in ARM strengthens our position as a forward-thinking, collaborative CDMO that’s aligned with the future of regenerative medicine. It’s one more way we ensure our partners are supported by an organization that is connected, informed, and relentlessly committed to advancing this field.
When you work with Excellos, you benefit from our:
- Direct access to cutting-edge insights and global best practices through ARM’s network and resources
- Commitment to regulatory excellence and policy alignment, helping your programs stay ahead of the curve
- Collaborative approach to scientific and technological innovation—from development to manufacturing
- Engagement in a thriving ecosystem of thought leaders, innovators, and changemakers
- Focus on quality, speed, and scalability—with a pulse on where the industry is headed
Together with ARM and its member organizations, we’re working to make safe, effective, and transformative therapies more accessible to those who need them most.
Ready to accelerate your cell and gene therapy program?
Let’s build the future of regenerative medicine—together. Contact us today to learn more about partnering with Excellos.
